The Medicare coverage memo for next-generation DNA sequencing (NGS) was reopened to allow for NGS testing for other than late-stage cancers, but stakeholders are urging the U.S. Centers for Medicare ...
As demand for high-throughput genomic profiling continues to grow, laboratories and research organizations face increasing pressure to maximize sample throughput The post Optimizing Sample Throughput ...